Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
, data protection, intellectual property, artificial intelligence, legal technology, blockchain, or other areas that inform the impact of technology on human life or the practice of law. The Visiting Chair
-
be considered: Fundamentals of Artificial Intelligence and Machine Learning, Robotics, Computer Vision, Cyber security, Cyberphysical Systems, and Quantum Computing. Candidates with experience in
-
be considered: Fundamentals of Artificial Intelligence and Machine Learning, Robotics, Computer Vision, Cyber security, Cyberphysical Systems, and Quantum Computing. Candidates with experience in
-
diagnostics, genome design, and cellular design and engineering. New approaches that incorporate evolution, selection methods, machine learning, and artificial intelligence are also of interest, as are methods
-
, data engineering at scale, real-time predictive analytics and control, AI systems, physical artificial intelligence, cyber-physics systems, and mechatronics. We seek candidates who can demonstrate an
-
Information Technology Law or one of its sub-fields, such as cybersecurity, privacy, data protection, intellectual property, artificial intelligence, legal technology, blockchain, or other areas that inform the impact of
-
monitoring, and artificial intelligence applications · Elucidating mechanisms (e.g., systemic inflammation, gut microbiota, etc.) underlying the impact of physical activity and sedentary behavior on mental
-
of biological, artificial, and collective intelligence through collaboration across a wide range of fields. We seek enthusiastic scientists and scholars who will embrace the chance to help set the agenda for our
-
), Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations (CLEAR-AD.org), Artificial Intelligence for Alzheimer’s Disease (AI4AD.org), Alzheimer’s Disease Metabolomics Consortium
-
), Centrally-linked longitudinal peripheral biomarkers of AD in multi- ethnic populations (CLEAR-AD), Artificial Intelligence for Alzheimer’s Disease (AI4AD), Alzheimer’s Disease Metabolomics Consortium (ADMC